The risk of lipolysis in visceral adipose tissue is higher than that in subcutaneous adipose tissue, which causes patients with visceral fat accumulation-induced central obesity to be universally insulin resistant and much more likely to develop NAFLD secondary to their increasing FFA content [19]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.